Form 8-K · Current report
Schlumberger 8-K, filed Oct 23, 2026
- Filed
- CIK
- 0000087347
- Accession no.
- 0001193125-26-429435
Summary
SLB reported third-quarter 2026 revenue of $9.45 billion, up 5% sequentially and 6% year on year, with GAAP diluted EPS of $0.49 and net income of $735 million. The company also announced a roughly $3.4 billion cash acquisition of Kelvion and completed its purchase of S&P Global Energy's geoscience and petroleum engineering software portfolio.
Key points
- SLB reported third-quarter 2026 revenue of $9.45 billion, up 5% sequentially and 6% year on year.
- GAAP diluted EPS was $0.49, down 6% sequentially and 2% year on year; adjusted EPS was $0.64.
- SLB's board approved a quarterly cash dividend of $0.295 per share.
- SLB agreed to acquire Kelvion, a thermal management and heat exchange technology provider, for approximately $3.4 billion in cash plus assumed debt, with the deal expected to close in the first half of 2027.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. The Third-Quarter 2026 Earnings Release furnished as Exhibit 99 hereto, which is incorporated by reference into this Item 2.02, was posted on the SLB internet website (https://investorcenter.slb.com/financial-information/quarterly-results) on October 23, 2026. In accordance with General Instructions B.2. of Form 8-K, the information will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor will it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), except as expressly set forth by specific…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.